Study of the Relationship Between Curarization and Pneumoperitoneum in Laparoscopic Surgery
Launched by POITIERS UNIVERSITY HOSPITAL · May 27, 2025
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating how the use of a muscle relaxant called curare affects laparoscopic surgery, where doctors perform operations through small cuts in the abdomen. In this type of surgery, a gas is used to create space in the abdomen, allowing the surgeons to work more easily. The trial aims to understand the relationship between how much curare is used and the pressure of the gas during surgery. This is important because even if the muscle relaxant seems to be effective, it might not always create the best conditions for surgery.
To participate in this study, individuals must be adults aged 65 to 74 who are scheduled for robot-assisted laparoscopic surgery performed by two specific surgeons known for their similar techniques. Participants can expect to help researchers learn more about how to improve surgical conditions during laparoscopic procedures, which could lead to better outcomes. This trial is not yet recruiting participants, but it promises to explore important factors that could enhance the effectiveness of laparoscopic surgeries.
Gender
ALL
Eligibility criteria
- • Major patient, operated on by robot-assisted laparoscopic surgery, by two surgeons targeted for their similar working surgical technique.
About Poitiers University Hospital
Poitiers University Hospital is a leading academic medical institution dedicated to advancing healthcare through innovative clinical research and trials. As a prominent sponsor of clinical studies, the hospital leverages its multidisciplinary expertise and state-of-the-art facilities to explore new therapeutic interventions and improve patient outcomes. With a commitment to ethical standards and patient safety, Poitiers University Hospital collaborates with healthcare professionals, researchers, and institutions to facilitate groundbreaking studies that contribute to medical knowledge and enhance treatment protocols across various specialties.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported